Our results imply two possibilities for rapid therapeutic intervention: 1) the severity of SMA after birth can be predicted through the analysis of maternal peripheral blood, and 2) inducing maternal SMN expression could serve as an effective treatment strategy for the foetus. Here, SMN1 is linked to proximal spinal muscular atrophy.